Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Cash from Investing Activities (2016 - 2024)

Historic Cash from Investing Activities for HealthLynked (HLYK) over the last 9 years, with Q4 2024 value amounting to $425000.0.

  • HealthLynked's Cash from Investing Activities fell 6417.22% to $425000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $422402.0, marking a year-over-year decrease of 8795.24%. This contributed to the annual value of $422402.0 for FY2024, which is 8795.24% down from last year.
  • Latest data reveals that HealthLynked reported Cash from Investing Activities of $425000.0 as of Q4 2024, which was down 6417.22% from -$2598.0 recorded in Q1 2024.
  • Over the past 5 years, HealthLynked's Cash from Investing Activities peaked at $2.6 million during Q3 2020, and registered a low of -$613631.0 during Q4 2020.
  • For the 5-year period, HealthLynked's Cash from Investing Activities averaged around $337912.9, with its median value being -$6775.0 (2021).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 4597966.63% in 2020, then crashed by 19752.67% in 2022.
  • Over the past 5 years, HealthLynked's Cash from Investing Activities (Quarter) stood at -$613631.0 in 2020, then surged by 98.9% to -$6775.0 in 2021, then crashed by 90.2% to -$12886.0 in 2022, then skyrocketed by 9305.58% to $1.2 million in 2023, then tumbled by 64.17% to $425000.0 in 2024.
  • Its Cash from Investing Activities stands at $425000.0 for Q4 2024, versus -$2598.0 for Q1 2024 and $1.2 million for Q4 2023.